Results 101 to 110 of about 8,627 (176)

Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate

open access: yesPatient Preference and Adherence, 2009
L Bellamy1, N Rosencher1, BI Eriksson21Anaesthesiology Department, Hôpital Cochin (AP-HP), René Descartes University, Paris 75014 France; 2Orthopaedic Department, University Hospital Sahlgrenska/Ostra, Gothenburg, SwedenAbstract: The
L Bellamy, N Rosencher, BI Eriksson
doaj  

A Phase 1 Study to Assess the Effect of Fruquintinib on the Pharmacokinetics of P‐gp and BCRP Substrates in Healthy Subjects

open access: yesClinical and Translational Science
Fruquintinib, a highly selective, oral inhibitor of all three vascular endothelial growth factor receptors (−1, −2, and −3), is approved for previously treated metastatic colorectal cancer.
Martha Gonzalez   +5 more
doaj   +1 more source

Development & validation of RP-HPLC method for estimation of Dabigatran etexilate mesylate from capsule dosage form

open access: yes, 2017
An accurate, sensitive and rapid RP-HPLC method has been developed and validated for the estimation of Dabigatran etexilate mesylate from capsule Dosage form.
Patel, Bhavna   +3 more
core  

Dabigatran etexilate for preventing stroke in patients with non-valvular atrial fibrillation - results from daily application

open access: yes, 2014
Primjena dabigatran-eteksilata u bolesnika koji boluju od nevalvularne atrijske fibrilacije u svrhu sprječavanja tromboembolijskih incidenata inicijalno je ohrabrena vrlo povoljnim rezultatima učinkovitosti i sigurnosti iz pivotalne kliničke studije RE ...
Počanić, Darko
core   +1 more source

A single-dose, four-cycle, fully repetitive crossover bioequivalence of dabigatran etexilate in Chinese. [PDF]

open access: yesBMC Pharmacol Toxicol
Yang Z   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy